China’s Public Payer Proposes Relaxing Novel Chemical Drug Pricing

 
• By Dexter Jie Yan
  
drug pricing
companies allowed to set initial list prices of innovative chemical drugs without govt intervention in China • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from China

More from Asia